2025 SPS Seattle | Caplacizumab in the Immune-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Setting

2025 SPS Seattle | Caplacizumab in the Immune-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Setting

0% Complete

Course Content

This material is non-CME, no credits are available, and a certificate will not be provided upon completion.

Course Details

Duration
0.00 hour
Released
Oct 5, 2025
Last Review
Oct 5, 2025
Expires
Oct 5, 2026

Target Audience

Pharmacists

Faculty & Disclosure

Faculty

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE

Accreditation

NA